{
    "1641320606762147840": {
        "attachments": {
            "media_keys": [
                "3_1641320603985625090"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-03-30T06:05:01.000Z",
        "edit_history_tweet_ids": [
            "1641320606762147840"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 65,
                    "normalized_text": "HIV",
                    "probability": 0.739,
                    "start": 63,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 5,
                    "start": 0,
                    "tag": "News"
                },
                {
                    "end": 20,
                    "start": 10,
                    "tag": "Investors"
                },
                {
                    "end": 31,
                    "start": 25,
                    "tag": "Media"
                }
            ],
            "mentions": [
                {
                    "end": 46,
                    "id": "3019793950",
                    "start": 39,
                    "username": "ViiVHC"
                }
            ],
            "urls": [
                {
                    "description": "At GSK, we unite science, technology and talent to get ahead of disease together",
                    "display_url": "gsk.com",
                    "end": 217,
                    "expanded_url": "https://www.gsk.com",
                    "images": [
                        {
                            "height": 157,
                            "url": "https://pbs.twimg.com/news_img/1767046796746907648/Q1o-vgzt?format=png&name=orig",
                            "width": 350
                        },
                        {
                            "height": 150,
                            "url": "https://pbs.twimg.com/news_img/1767046796746907648/Q1o-vgzt?format=png&name=150x150",
                            "width": 150
                        }
                    ],
                    "start": 194,
                    "status": 200,
                    "title": "Home | GSK",
                    "unwound_url": "https://www.gsk.com/en-gb/",
                    "url": "https://t.co/iq6ccrYH5Q"
                },
                {
                    "display_url": "pic.twitter.com/iaJ7uRUUuL",
                    "end": 241,
                    "expanded_url": "https://twitter.com/GSK/status/1641320606762147840/photo/1",
                    "media_key": "3_1641320603985625090",
                    "start": 218,
                    "url": "https://t.co/iaJ7uRUUuL"
                }
            ]
        },
        "id": "1641320606762147840",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4074,
            "like_count": 18,
            "quote_count": 0,
            "reply_count": 2,
            "retweet_count": 5
        },
        "text": "#News for #Investors and #Media: Today @ViiVHC, our specialist HIV company, have announced progress in their commitment to voluntary licencing for populations with unmet needs. \n\nFind out more: https://t.co/iq6ccrYH5Q https://t.co/iaJ7uRUUuL"
    }
}